Detalhe da pesquisa
1.
Systematic review of the barriers and facilitators to dietary modification in people living with type 2 diabetes and pre-diabetes from South Asian ethnic populations.
Diabet Med
; 40(8): e15132, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37151165
2.
Clinical practice guidelines for management of hyperglycaemia in adults with diabetic kidney disease.
Diabet Med
; 39(4): e14769, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35080257
3.
Association of British Clinical Diabetologists (ABCD) and Diabetes UK joint position statement and recommendations on the use of sodium-glucose cotransporter inhibitors with insulin for treatment of type 1 diabetes (Updated October 2020).
Diabet Med
; 38(2): e14458, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33179277
4.
A roadmap to recovery: ABCD recommendations on risk stratification of adult patients with diabetes in the post-COVID-19 era.
Diabet Med
; 38(3): e14462, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33230813
5.
Real-world data of a digitally enabled, time-restricted eating weight management program in public sector workers living with overweight and obesity in the United Kingdom: A service evaluation of the Roczen program.
Obes Sci Pract
; 10(1): e730, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38344678
6.
A Narrative Review of Chronic Kidney Disease in Clinical Practice: Current Challenges and Future Perspectives.
Adv Ther
; 39(1): 33-43, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34739697
7.
Defining the Role of SGLT2 Inhibitors in Primary Care: Time to Think Differently.
Diabetes Ther
; 13(5): 889-911, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35349120
8.
New Therapeutic Horizons in Chronic Kidney Disease: The Role of SGLT2 Inhibitors in Clinical Practice.
Drugs
; 82(2): 97-108, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34932209
9.
Glucagon-Like Peptide 1 Receptor Agonist Usage in Type 2 Diabetes in Primary Care for the UK and Beyond: A Narrative Review.
Diabetes Ther
; 12(9): 2267-2288, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34309808
10.
Optimising the Heart Failure Treatment Pathway: The Role of SGLT2 Inhibitors.
Drugs
; 81(11): 1243-1255, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34160822
11.
Association of British Clinical Diabetologists (ABCD) and Diabetes UK joint position statement and recommendations for non-diabetes specialists on the use of sodium glucose co-transporter 2 inhibitors in people with type 2 diabetes (January 2021).
Clin Med (Lond)
; 21(3): 204-210, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34001571
12.
Correction to: SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c-Translating Evidence into Practice.
Diabetes Ther
; 10(5): 1623-1624, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31321747
13.
SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c-Translating Evidence into Practice.
Diabetes Ther
; 10(5): 1595-1622, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31290126
14.
Management of diabetes in patients with COVID-19.
Lancet Diabetes Endocrinol
; 8(8): 668, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32707111
15.
Type 2 diabetes is associated with reduced ATP-binding cassette transporter A1 gene expression, protein and function.
PLoS One
; 6(7): e22142, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21829447